NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and East
key details
| Value | £441,994,547 |
|---|---|
| Status | active |
| Category (CPV) | 33600000 |
| Region | East Midlands, East of England, London, North East, North West, South East, South West, West Midlands, Yorkshire and the Humber |
| Deadline | 4 Jun 2021 |
| Contract start | 1 Sept 2021 |
| Contract end | 31 Aug 2023 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-b06ade27-8ac0-4667-bb12-fa1e94dda13e |
description
Invitation to offer for NHS Framework Agreement, Branded Medicines for London and South of England. Offer ref number: CM/PHR/20/5598 Lot 01 - LONDON Branded Medicines - Tranche B.
Period of Framework 01/09/21 - 31/08/23 with option to extend for a period of 24 months.
Lot 02 - LONDON Branded Medicines - Annual Tranche.
Period of framework 01/09/21 - 31/08/22 with option to extend for period of 12 months.
Lot 03 - SOUTH of England Tranche A.
Period of Framework: 01/09/21 - 31/08/23 with option for a period of 24 months Lot 04- SOUTH of England - Tranche B.
Period of framework:01/09/21 - 31/08/22 with option to extend for a period of 12 months.
Lot 05 - SOUTH of England Annual Tranche.
Period of Framework:01/09/21 - 31/08/22 with option to extend for a period of 12 months.
Lot 06 - Mids & East and North of England Regions - Bevacizumab.
Period of Framework: 01/09/21 - 28/02/22 with option to extend for a period of 6 months.
documents
- https://www.contractsfinder.service.gov.uk/Notice/9128ce5e-274b-4771-8d4c-dd29e898e7e0 , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 7 May 2021 | Tender (tender) | · | 4059a678-516a-48ce-b80a-37abad223085-434729 |
more from NHS England
- Urgent Award - haematological screening · £16,202 · 29 Jul 2026
- HSCN-AWS Connectivity Service for Spine · £228,060 · 29 Jul 2026
- Incentive Voucher Provider · £60,000 · 29 Jul 2026
- CRM for NHSE participant/candidate data 26-27 · £56,640 · 28 Jul 2026
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.